| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Cardiology and Pulmonary Medicine Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.
Study objectives: Many reports have shown the efficacy of talc to induce an effective pleurodesis. However, there is little information about the side effects related to this sclerosing agent. The objective of this experimental study is to recognize the systemic distribution of talc after its instillation into the pleural space of rats.
Design: Forty animals were assigned to receive talc through a catheter placed in a left minimal thoracotomy. They were randomly divided in two groups: group 1 received 20 mg of talc and group 2 received 10 mg in the same total volume of 1 mL of saline solution. Half of the animals in each group were killed 24 h and the other half 48 h after the procedure. BAL was collected and histologic sections of both lungs, chest wall, liver, kidneys, spleen, heart, and brain were examined. Crystals were tracked using polarized light and we have used a "birefringent particles index of deposition" in an attempt to quantify the amount or talc encountered in different organs.
Results: Talc crystals were found in every organ of all animals studied (100%). There was no statistical difference either on the dose of talc used or in the time of death. The amount of talc was statistically different in the organs, which made us divagate about a route of absorption.
Conclusions: We conclude that there is a progressive deposition of talc particles in the organs examined after its administration into the pleural space of normal rats. This report suggests that there is a rapid absorption of talc through the pleural surface and that the systemic distribution thereafter is not dose related. Further studies are necessary to assess the amount of crystals and the clinical correlation to these findings.
Key Words: malignant pleural effusion • sclerosing agent • talc pleurodesis
This article has been cited by other articles:
|
|
 |
|
  E. Marchi, F. S. Vargas, L. R. Teixeira, M. M. P. Acencio, L. Antonangelo, and R. W. Light Intrapleural Low-Dose Silver Nitrate Elicits More Pleural Inflammation and Less Systemic Inflammation Than Low-Dose Talc Chest, September 1, 2005; 128(3): 1798 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al. Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion Chest, March 1, 2005; 127(3): 909 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Maskell, Y. C. G. Lee, F. V. Gleeson, E. L. Hedley, G. Pengelly, and R. J. O. Davies Randomized Trials Describing Lung Inflammation after Pleurodesis with Talc of Varying Particle Size Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 377 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Marchi, F. S. Vargas, M. M. P. Acencio, L. Antonangelo, L. R. Teixeira, E. H. Genofre, and R. W. Light Talc and Silver Nitrate Induce Systemic Inflammatory Effects During the Acute Phase of Experimental Pleurodesis in Rabbits Chest, June 1, 2004; 125(6): 2268 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Langley, R. Kalra, N. C. Mishra, F. F. Hahn, S. Razani-Boroujerdi, S. P. Singh, J. M. Benson, J. C. Pena-Philippides, E. B. Barr, and M. L. Sopori A Biphasic Response to Silica: I. Immunostimulation Is Restricted to the Early Stage of Silicosis in Lewis Rats Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 823 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Czerny, A. Salat, T. Fleck, W. Hofmann, D. Zimpfer, F. Eckersberger, W. Klepetko, E. Wolner, and M.-R. Mueller Lung wedge resection improves outcome in stage I primary spontaneous pneumothorax Ann. Thorac. Surg., May 1, 2004; 77(5): 1802 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nguyen, V. Varma, R. Perez, and D. M. Schuster CT with Histopathologic Correlation of FDG Uptake in a Patient with Pulmonary Granuloma and Pleural Plaque Caused by Remote Talc Pleurodesis Am. J. Roentgenol., January 1, 2004; 182(1): 92 - 94. [Full Text] [PDF]
|
|
|
|
|
|
J. F. Montes, J. Ferrer, M. A. Villarino, B. Baeza, M. Crespo, and J. Garcia-Valero Influence of Talc Dose on Extrapleural Talc Dissemination after Talc Pleurodesis Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Artemiou, G.-M. Marta, W. Klepetko, E. Wolner, and M.-R. Muller Pleurovenous shunting in the treatment of nonmalignant pleural effusion Ann. Thorac. Surg., July 1, 2003; 76(1): 231 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Marchi, L. R. Teixeira, F. Vargas, P. Astoul, A. Fraticelli, A. Robaglia-Schlupp, and P. Cau Talc for Pleurodesis: Hero or Villain? Chest, July 1, 2003; 124(1): 416 - 417. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Spiegler, A. N. Hurewitz, and M. L. Groth Rapid Pleurodesis for Malignant Pleural Effusions Chest, June 1, 2003; 123(6): 1895 - 1898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Light Talc for Pleurodesis? Chest, November 1, 2002; 122(5): 1506 - 1508. [Full Text] [PDF]
|
|
|
|
|
|
A. Fraticelli, A. Robaglia-Schlupp, H. Riera, S. Monjanel-Mouterde, P. Cau, and P. Astoul Distribution of Calibrated Talc After Intrapleural Administration: An Experimental Study in Rats Chest, November 1, 2002; 122(5): 1737 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ferrer, J. F. Montes, M. A. Villarino, R. W. Light, and J. Garcia-Valero Influence of Particle Size on Extrapleural Talc Dissemination After Talc Slurry Pleurodesis* Chest, September 1, 2002; 122(3): 1018 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Olivares-Torres, R. Laniado-Laborin, C. Chavez-Garcia, C. Leon-Gastelum, A. Reyes-Escamilla, and R. W. Light Iodopovidone Pleurodesis for Recurrent Pleural Effusions* Chest, August 1, 2002; 122(2): 581 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ferrer, M. A. Villarino, J. M. Tura, A. Traveria, and R. W. Light Talc Preparations Used for Pleurodesis Vary Markedly From One Preparation to Another Chest, June 1, 2001; 119(6): 1901 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. M. de Campos, F. S. Vargas, E. d. C. Werebe, P. Cardoso, L. R. Teixeira, F. B. Jatene, and R. W. Light Thoracoscopy Talc Poudrage : A 15-Year Experience Chest, March 1, 2001; 119(3): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. GARY LEE, L. R. TEIXEIRA, C. J. DEVIN, M. A. C. VAZ, F. S. VARGAS, P. J. THOMPSON, K. B. LANE, and R. W. LIGHT Transforming Growth Factor-{beta}2 Induces Pleurodesis Significantly Faster than Talc Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 640 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Light Talc Should Not Be Used for Pleurodesis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2024 - 2026. [Full Text]
|
|
|
|
 |
|
 G ANTUNES and E NEVILLE Management of malignant pleural effusions Thorax, December 1, 2000; 55(12): 981 - 983. [Full Text]
|
|
|
|
|
|
Y C G Lee, K B Lane, R E Parker, D S Ayo, J T Rogers, R W Diters, P J Thompson, and R W Light Transforming growth factor beta 2 (TGFbeta 2) produces effective pleurodesis in sheep with no systemic complications Thorax, December 1, 2000; 55(12): 1058 - 1062. [Abstract] [Full Text]
|
|
|
|
|
|
A. H. DIACON, C. WYSER, C. T. BOLLIGER, M. TAMM, M. PLESS, A. P. PERRUCHOUD, and M. SOLER Prospective Randomized Comparison of Thoracoscopic Talc Poudrage under Local Anesthesia versus Bleomycin Instillation for Pleurodesis in Malignant Pleural Effusions Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1445 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Dresler Systemic Distribution of Talc Chest, July 1, 1999; 116(1): 266 - 266. [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
